Korea Stock Market Today, Oct 7, 2026: KOSPI -1.98%, KOSDAQ Drops Below 900

· KOSDAQ · KOSPI · Market Close · Samsung Electronics

Korea market close Oct 7, 2026: KOSPI 6,803.90 (-1.98%), KOSDAQ 898.43 (-2.34%)

KOSPI closed at 6,803.90, down 1.98%, and KOSDAQ closed at 898.43, down 2.34%, falling back below 900 as investors held back ahead of Samsung Electronics' third-quarter preliminary earnings and foreign investors sold heavily. Individual themes still moved on their own news: Seoul Express Bus Terminal redevelopment, a Russian plague-lab accident, and record K-beauty exports.

IndexCloseChange
KOSPI6,803.90-1.98%
KOSDAQ898.43-2.34%

1. Samsung earnings ahead, heavy foreign selling — KOSPI and KOSDAQ fall together

Korean markets weakened despite strength on Wall Street, as caution before Samsung Electronics' third-quarter preliminary earnings announcement combined with heavy foreign selling. KOSPI fell 1.98% to 6,803.90 and KOSDAQ fell 2.34% to 898.43, giving up the 900 level again. Foreign and institutional investors were net sellers on both KOSPI and KOSDAQ, and reports put foreign net selling on KOSPI in the trillions of won.

2. Seoul Express Bus Terminal redevelopment hopes — Cheonil Express and Dongyang Express hit upper limit

Related stocks rallied on reports that Seoul's Seocho District is speeding up private development projects, including a mixed-use redevelopment of the Seoul Express Bus Terminal. The site covers about 146,260 square meters, and Seoul is reportedly in pre-negotiation with Shinsegae Central City and the terminal operator on a mixed-use plan. Cheonil Express holds 16.67% of the terminal and Dongyang Express holds 0.17%, so hopes of an asset revaluation pushed both to their daily upper limit. Expectations of higher demand for construction materials also spread to Sampyo Cement and Daesung Industrial.

3. Plague-lab accident in Russia — diagnostic kit and infectious disease stocks surge

Reports that a researcher at a plague laboratory in Siberia died after being infected following an accident in which a tube containing the pathogen was broken raised infectious disease alertness. The U.S. government is reportedly watching the situation, and talk of further disclosures and possible travel advisories fed expectations of higher demand for diagnostics. There is no confirmed large-scale community spread so far; the move was driven mainly by alarm over the lab accident. Humasis jumped in the high 20% range intraday, and diagnostic names GC MS, GenMatrix, Lab Genomics, SUGENTECH and Seegene also rose.

4. Infectious disease worries spread — rotation into treatment, devices and pharma

After the diagnostic kit rally, attention spread to treatments, vaccines and respiratory medical devices across the infectious disease value chain, drawing buying into pharma and biotech. Shin Poong Pharm, Green Life Science, Mek ICIS, Joa Pharm and Cellid were in focus. Mek ICIS is linked to respiratory medical devices and Cellid to a vaccine platform. Kukje Pharma had a separate stock-specific factor that day, a gift of shares by the owner's family, so it is better viewed as a stock with overlapping news than as a plague-theme stock alone.

5. Record K-beauty exports in September — cosmetics stocks rise

Korea's cosmetics exports in September reached $1.51 billion, the first time above $1.5 billion and a monthly record, lifting K-beauty stocks. Exports rose 31.4% from a year earlier, with growth across the U.S., China and Europe, and shipments to China rose sharply from the previous month. Growth in indie brands and wider global distribution channels spread earnings expectations from brands to ODM/OEM makers and distribution. Hankook Cosmetics Manufacturing, VT, Able C&C and Cosmecca Korea were in focus.

Quick FAQ

Why did KOSPI fall almost 2% on Oct 7?
Caution before Samsung Electronics' third-quarter preliminary earnings and heavy foreign net selling pushed the index down 1.98% to 6,803.90, even though U.S. stocks were strong.

Why did Cheonil Express and Dongyang Express hit the upper limit?
Reports of a mixed-use redevelopment of the Seoul Express Bus Terminal raised hopes of an asset revaluation for the two stockholders in the terminal, which hold 16.67% and 0.17%.

Did diagnostic kit stocks rise because of a plague outbreak?
They rose because of a reported fatal accident at a Russian plague laboratory. No large-scale community spread has been confirmed, and the move was driven mostly by alarm.

This brief is our own summary based on same-day Korean market coverage and Daum Finance closing data; it is not a translation and not investment advice. See our Disclaimer and evidence labels.
Stock Anatomy · Last checked: October 7, 2026

Related